Additionally, the induced level of IL-7 by melatonin enhances the anti-tumor activity of CD8+ T-cells in HCC patients and has been suggested to be a therapeutic candidate for HCC treatment (Teng et al. 2018). The gene discussed is IL7; the disease is neoplasm.